Introducing our founder and Chief Regulatory Officer, Damien Bové

Leading ADACT’s team of electronic cigarette, vaping, CBD and hemp industry experts is Damien Bové BSc (Sci. Hons), MSc (Sci. Open), ICR

Damien Bové

Damien brings an entrepreneurial and creative spirit to his role as ADACT’s Chief Regulator Officer. He leads ADACT’s team of global regulatory compliance experts for the electronic cigarette, vaping, CBD and hemp industries and travels to industry events around the world.

Studies

  • 1996 to 2000 - Pharmaceutical Sciences BSc (Hons) at University of Bradford
  • 2001 to 2003 - Frontiers of Medical Science MSc at Open University

Standards Committees

  • 2019 to Present - Committee member for Electronic Cigarettes and E-liquids standards (EN, CEN, ESO) at the British Standards Institute (BSI)

Professional Career

  • 1998 to 1999 - Academic Liaison (SmithKline Beecham)
  • 2000 to 2001 - Research Assistant to Research Associate (GlaxoSmithKline)
  • 2001 to 2002 - Research Assistant to Commercial Consultant)
  • 2002 to 2003 - Research Assistant to Director of Emergent Product Services)
  • 2004 to Present - Independent consultant (Medical Technologies)
  • 2009 to 2013 - Director and Regulatory Officer (IDA)
  • 2012 to Present: Chief Regulatory Officer (ADACT Medical Ltd)
  • 2013 to 2015 - Director of Product Development (Yorkshire Biotec)
  • 2014 - Director Innovation Centre (The HUB) (Charnwood Biomedical Campus)

Guest speaker / Panelist

  • 16 July 2018 - All-party parliamentary group to discuss vaping regulation post-Brexit
  • 7 November 2018 - Regulation and compliance at CTAUK AGM
  • 25 April 2019 - Novel Foods, Hemp and CBD Expo at NEC Birmingham
  • 9 May 2019 - Future of vape regulations and CBD at UKVIA
  • 11 July 2019 - Cannabidoil: Food Supplements Special Interest Group with Consult2deliver
  • 18 July 2019 - Board meeting, campaigning for fair and appropriate regulations with UKVIA
  • 28 September 2019 - CEN standards meeting for chemicals in vaping in Sicily
  • 2 October 2019 - ISO standards representing UKVIA
  • 28 October 2019 - PMTA public meeting with U.S. Food and Drug Administration (FDA)

Further training

  • 2000 - Clinical Research Overview (Covance)
  • 2003 - Advanced Issues in Clinical Research (Imperial College London)
  • 2006 - The Lifecycle of NHS Clinical Trials (ICR)
  • 2010 - Advanced Therapy Regulations
  • 2014 - Cancer Innovation Exchange (East Midlands Academic Health Science Network)
  • 2014 - Module 3 dossiers for Traditional Herbal Medicinal Products (British Herbal Medicine Association)
  • 2016 - Regulation of Herbal Medicines (Callisto Consulting Ltd)

Memberships

  • 2003 to 2004 - Member of the Health Economics Study Group
  • 2007 to Present - Registered Member of the Royal Institute of Clinical Research (ICR)
  • 2017 to Present - Member of the UK Vaping Industry Association (UKVIA)
  • 2019 to Present - Member of the Information Commissioner’s Office (ICO)
  • 2019 to Present - Member of The Medical Cannabis Clinicians Society (MCCS)
  • 2020 to Present - Member of Cooperation Centre for Scientific Research Relative to Tobacco (CORESTA)

Other Work

  • 2015 to 2018 - Regulatory Officer, European Electronic Cigarette Business Association (ECCBA)
  • 2000 to Present - Works with the MHRA, FDA, Health Canada, EMEA and UKVIA amongst others

Peer review

  • 2015 to Present - Cell and Gene Therapy Insights